Immunovant

IMVT13F as of Jun 30, 2026 · next update ~Nov 14

Limited coverage

Only 1 fund we track owns this stock, so quarterly sentiment and aggregates may be sparse.

Who's buying IMVT

Top funds mostly added to Immunovant in Q1 (Jan⁠–⁠Mar)

Buying:

Funds1InsidersCongress

Top funds
1 of 1 bought more, 0 sold some. Largest: DME Capital, $3.6M (0% of its portfolio).
Insiders
1 insider bought, 40 sales in 12 months.
Congress
No trades disclosed in the last 12 months.

1 fund$3.6M held0.1% avg. weightQ1: 1 bought / 0 sold

13F reports are a snapshot as of Mar 31, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).

Share price · market data, not from 13F reports

Q2 2026

Insider trades (Form 4)

Last 2 years · 72 filings

Net buying$706.42M

Date	Insider	Type	Shares	Price	Value
Oct 21, 2026	Jay S Stout CTO	Sold	2,595	$28.94	$75K
Oct 7, 2026	Jay S Stout CTO	Sold	3,809	$32.06	$122K
Oct 7, 2026	Christopher Van Tuyl	Sold	1,327	$32.06	$43K
Oct 7, 2026	Melanie Gloria COO	Sold	2,241	$32.06	$72K
Oct 2, 2026	Eric Venker CEO	Sold	3,506	$34.11	$120K
Sep 23, 2026	Christopher Van Tuyl	Sold	2,846	$36.36	$103K
Aug 28, 2026	Atul Pande Director	Sold	1,500	$43.27	$65K
Aug 20, 2026	Melanie Gloria COO	Sold	3,056	$44.16	$135K
Jul 24, 2026	Atul Pande Director	Sold	1,500	$39.80	$60K
Jul 23, 2026	Tiago Girao CFO	Sold	6,798	$38.69	$263K
Jul 23, 2026	Jay S Stout CTO	Sold	2,857	$38.69	$111K
Jul 8, 2026	Melanie Gloria COO	Sold	2,036	$39.55	$81K
Jul 8, 2026	Christopher Van Tuyl	Sold	1,206	$39.55	$48K
Jul 8, 2026	Jay S Stout CTO	Sold	3,487	$39.55	$138K
Jul 2, 2026	Eric Venker CEO	Sold	3,092	$38.48	$119K
Jun 26, 2026	Melanie Gloria COO	Sold	17,714	$38.31	$679K
Jun 26, 2026	Jay S Stout CTO	Sold	40,000	$38.31	$1.53M
Jun 26, 2026	Christopher Van Tuyl	Sold	17,824	$38.31	$683K
Jun 26, 2026	Tiago Girao CFO	Sold	10,000	$38.46	$385K
Jun 26, 2026	Atul Pande Director	Sold	1,500	$38.01	$57K
Jun 18, 2026	Christopher Van Tuyl	Sold	2,634	$35.39	$93K
Jun 15, 2026	Atul Pande Director	Sold	1,500	$34.02	$51K
May 28, 2026	Andrew J. Fromkin Director	Sold	221,951	$33.51	$7.44M
May 20, 2026	Melanie Gloria COO	Sold	3,115	$32.45	$101K
May 20, 2026	Atul Pande Director	Sold	6,000	$32.00	$192K
May 1, 2026	Robert Graham Susman Director	Sold	2,502	$27.17	$68K
Apr 23, 2026	Tiago Girao CFO	Sold	25,760	$29.62	$763K
Apr 23, 2026	Jay S Stout CTO	Sold	2,754	$29.62	$82K
Apr 8, 2026	Christopher Van Tuyl	Sold	5,165	$24.83	$128K
Apr 8, 2026	Melanie Gloria COO	Sold	8,722	$24.83	$217K
Apr 8, 2026	Jay S Stout CTO	Sold	10,132	$24.83	$252K
Apr 2, 2026	Eric Venker CEO	Sold	14,229	$24.10	$343K
Mar 18, 2026	Christopher Van Tuyl	Sold	2,877	$24.97	$72K
Feb 25, 2026	Melanie Gloria COO	Sold	3,238	$27.85	$90K
Jan 21, 2026	Jay S Stout CTO	Sold	1,977	$26.03	$51K
Jan 7, 2026	Jay S Stout CTO	Sold	1,203	$26.53	$32K
Dec 18, 2025	Christopher Van Tuyl	Sold	10,813	$26.91	$291K
Dec 12, 2025	Roivant Sciences Ltd. Director & 10% Owner	Bought	16,666,666	$21.00	$350.00M
Dec 1, 2025	Andrew J. Fromkin Director	Sold	22,249	$23.25	$517K
Dec 1, 2025	Douglas J. Hughes Director	Sold	15,000	$23.24	$349K
Nov 20, 2025	Melanie Gloria COO	Sold	12,626	$23.62	$298K
Oct 22, 2025	Michael Geffner	Sold	2,595	$19.03	$49K
Oct 22, 2025	Jay S Stout CTO	Sold	2,520	$19.03	$48K
Oct 8, 2025	Michael Geffner	Sold	1,272	$16.30	$21K
Oct 8, 2025	Jay S Stout CTO	Sold	1,585	$16.30	$26K
Jul 23, 2025	Jay S Stout CTO	Sold	2,805	$18.15	$51K
Jul 23, 2025	Michael Geffner	Sold	2,385	$18.15	$43K
Jul 9, 2025	Michael Geffner	Sold	1,160	$17.24	$20K
Jul 9, 2025	Jay S Stout CTO	Sold	1,519	$17.24	$26K
Apr 23, 2025	Jay S Stout CTO	Sold	1,925	$14.79	$28K
Apr 23, 2025	Michael Geffner	Sold	2,349	$14.79	$35K
Apr 16, 2025	Eva Renee Barnett CFO	Sold	2,993	$14.89	$45K
Apr 16, 2025	Peter Salzmann CEO	Sold	8,321	$14.89	$124K
Apr 9, 2025	Peter Salzmann CEO	Sold	28,094	$12.99	$365K
Mar 7, 2025	Andrew J. Fromkin Director	Sold	8,000	$19.60	$157K
Feb 19, 2025	William L. Macias	Sold	2,055	$20.86	$43K
Feb 19, 2025	Eva Renee Barnett CFO	Sold	2,814	$20.86	$59K
Feb 19, 2025	Peter Salzmann CEO	Sold	15,439	$20.86	$322K
Jan 22, 2025	Jay S Stout CTO	Sold	2,195	$23.59	$52K
Jan 22, 2025	Michael Geffner	Sold	2,657	$23.59	$63K
Jan 15, 2025	William L. Macias	Sold	2,383	$23.83	$57K
Jan 15, 2025	Eva Renee Barnett CFO	Sold	2,298	$23.83	$55K
Jan 15, 2025	Peter Salzmann CEO	Sold	8,767	$23.83	$209K
Jan 13, 2025	Roivant Sciences Ltd. Director & 10% Owner	Bought	16,845,010	$20.00	$336.90M
Jan 8, 2025	Eva Renee Barnett CFO	Sold	4,105	$24.10	$99K
Jan 8, 2025	Peter Salzmann CEO	Sold	5,105	$24.10	$123K
Dec 2, 2024	Atul Pande Director	Sold	7,750	$28.54	$221K
Dec 2, 2024	Douglas J. Hughes Director	Sold	5,425	$28.54	$155K
Nov 20, 2024	Mark S. Levine	Sold	3,650	$25.45	$93K
Nov 20, 2024	William L. Macias	Sold	3,353	$25.45	$85K
Nov 20, 2024	Eva Renee Barnett CFO	Sold	4,174	$25.45	$106K
Nov 20, 2024	Peter Salzmann CEO	Sold	16,692	$25.45	$425K